Close Menu

NEW YORK (GenomeWeb) – Inivata said today that it has completed a Series B fundraising round of £39.8 million ($52.6 million), which it will use to support commercialization of its existing liquid biopsy assay, as well as development of its technology for new indications.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.